The Foundation Assar Gabrielsson Prize recipients 2024 awarded

Rhea-AI Summary

The Assar Gabrielsson Foundation has announced the 2024 prize recipients: Anna Wenger and Sara Bjursten. Anna Wenger received the award for her advanced studies on malignant gliomas in children and adults, focusing on epigenetic differences and cancer stem cells, which could enhance diagnostics and treatment options. Sara Bjursten was recognized for her clinical research on immunotherapy and its side effects on the central nervous system. Both recipients will receive SEK 100,000 each for their research. The awards are managed by the Sahlgrenska Academy at the University of Gothenburg.

Positive

• Anna Wenger's research on malignant gliomas could lead to improved diagnostics and treatments.
• Sara Bjursten's work on immunotherapy may result in better early detection of side effects.
• Each awardee receives SEK 100,000, supporting further research.
• The Assar Gabrielsson Foundation has a long history of funding promising cancer research since 1962.

Negative

• No direct impact on Volvo's financial performance or stock value is evident from this award announcement.

GOTHENBURG, Sweden, May 16, 2024 /PRNewswire/ -- Assar Gabrielsson was one of the founders of Volvo. In accordance with his wishes, a fund was established for clinical research of cancer diseases. The fund has existed since 1962. It primarily supports research projects that are considered promising but have not yet reached the weight that provides funding from major research funds.

The Assar Gabrielsson Foundation has awarded Anna Wenger as the winner in the basic science research category and Sara Bjursten as the winner in the clinical research category. The prize recipients are rewarded with SEK 100,000 each as extra research grants, administered by the Sahlgrenska Academy at the University of Gothenburg.

"Anna Wenger is awarded the prize in the category of basic science research for advanced basic science studies on malignant gliomas in children and adults. The studies provide new knowledge about epigenetic differences and cancer stem cells different types of glioma. The results can be of great benefit for the development of better diagnostics and choice of treatment for patients with glioma," says Eva Forssell-Aronsson, professor at the University of Gothenburg and executive member of the Assar Gabrielsson Foundation in the citation.

"Sara Bjursten receives the award in the category of clinical research for clinically important and well-conducted research regarding immunotherapy in cancer patients. The studies provide new knowledge about side effects in the central nervous system, especially with regard to T cells and biomarkers in the blood. The results may lead to new strategies for early detection of side effects in these patients," says Professor Eva Forssell-Aronsson.

Journalists who want further information, please contact:

Torbjörn Holmström, Chairman of the Assar Gabrielssons Foundation, 031 66 10 73, or Eva Forssell-Aronsson, Executive Member of the Assar Gabrielsson Foundation, 070 372 26 26. 

For more information, please visit volvogroup.com  For frequent updates, follow us on X: @volvogroup 

The Volvo Group drives prosperity through transport and infrastructure solutions, offering trucks, buses, construction equipment, power solutions for marine and industrial applications, financing and services that increase our customers' uptime and productivity. Founded in 1927, the Volvo Group is committed to shaping the future landscape of sustainable transport and infrastructure solutions. The Volvo Group is headquartered in Gothenburg, Sweden, employs more than 100,000 people and serves customers in almost 190 markets. In 2023, net sales amounted to SEK 553 billion (EUR 48 billion). Volvo shares are listed on Nasdaq Stockholm.

This information was brought to you by Cision http://news.cision.com

https://news.cision.com/ab-volvo/r/the-foundation-assar-gabrielsson-prize-recipients-2024-awarded,c3982919

The following files are available for download:

https://mb.cision.com/Main/39/3982919/2802198.pdf	Press Release - The Foundation Assar Gabrielsson Prize recipients 2024 awarded
https://news.cision.com/ab-volvo/i/assargabrielsson-23,c3301334	AssarGabrielsson 23

View original content:https://www.prnewswire.com/news-releases/the-foundation-assar-gabrielsson-prize-recipients-2024-awarded-302148074.html

SOURCE AB Volvo

FAQ

Who are the recipients of the Assar Gabrielsson Prize 2024?

Anna Wenger and Sara Bjursten are the recipients of the Assar Gabrielsson Prize 2024.

What is the Assar Gabrielsson Foundation?

The Assar Gabrielsson Foundation funds clinical cancer research and has been active since 1962.

How much prize money do the Assar Gabrielsson Prize winners receive?

Each prize recipient receives SEK 100,000.

What are Anna Wenger's contributions in cancer research?

Anna Wenger conducted advanced studies on malignant gliomas, focusing on epigenetic differences and cancer stem cells.

What are Sara Bjursten's research findings?

Sara Bjursten's research on immunotherapy identified central nervous system side effects and potential early detection strategies.